Literature DB >> 28551176

A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.

Satya Prakash Shukla1, Joseph C Manarang1, D Gomika Udugamasooriya2.   

Abstract

Ligand multimerizations enhance the binding affinity towards cell surface biomarkers through their avidity effects. Typical linkers connect individual monomeric ligand moieties from one end (e.g., C- or N-terminus of a peptide) and exclusively target protein receptors. The n class="Chemical">lipid n>n class="Chemical">phosphatidylserine (PS) is normally present on the cytoplasmic side of the eukaryotic cell membrane, but in tumors and tumor endothelial cells, this negatively charged PS flips to the outer layer. We recently reported a PS binding peptide-peptoid hybrid (PPS1) that has distinct positively charged and hydrophobic residue-containing regions. The PPS1 monomer is inactive, and upon C-terminal dimerization (PPS1D1), it triggers cytotoxicity. In the current study, a unique series of PPS1 multimeric derivatives were synthesized by switching the linker from the C-terminus to an internal position. The unimportant fourth residue (N-lys) from the C-terminus was utilized to build the linker. The synthesis strategy was developed employing variations of (I) the linker size, (II) the number of positively charged residues, and (III) the number of hydrophobic regions. Cytotoxicity of these new derivatives on HCC4017 lung cancer cells showed that a minimum of two hydrophobic regions was important to retain the activity and that the shortest linker length was optimal for activity.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Multimers; Peptoids; Sequence modifications

Mesh:

Substances:

Year:  2017        PMID: 28551176      PMCID: PMC5555622          DOI: 10.1016/j.ejmech.2017.05.040

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  37 in total

Review 1.  Polyvalency: a promising strategy for drug design.

Authors:  David Vance; Mrinal Shah; Amit Joshi; Ravi S Kane
Journal:  Biotechnol Bioeng       Date:  2008-10-15       Impact factor: 4.530

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

Review 3.  Peptides and peptide hormones for molecular imaging and disease diagnosis.

Authors:  Seulki Lee; Jin Xie; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Aminophospholipid asymmetry: A matter of life and death.

Authors:  Krishnakumar Balasubramanian; Alan J Schroit
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

Review 5.  Peptide-receptor ligands and multivalent approach.

Authors:  Paolo Ruzza; Anna Marchiani; Nicola Antolini; Andrea Calderan
Journal:  Anticancer Agents Med Chem       Date:  2012-06       Impact factor: 2.505

6.  Solution-phase parallel synthesis of a diverse library of 1,2-dihydroisoquinolines.

Authors:  Nataliya A Markina; Raffaella Mancuso; Benjamin Neuenswander; Gerald H Lushington; Richard C Larock
Journal:  ACS Comb Sci       Date:  2011-03-16       Impact factor: 3.784

Review 7.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

8.  Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).

Authors:  Heather L Handl; Rajesh Sankaranarayanan; Jatinder S Josan; Josef Vagner; Eugene A Mash; Robert J Gillies; Victor J Hruby
Journal:  Bioconjug Chem       Date:  2007-06-26       Impact factor: 4.774

Review 9.  Tumour heterogeneity and cancer cell plasticity.

Authors:  Corbin E Meacham; Sean J Morrison
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

10.  Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.

Authors:  Tanvi J Desai; Jason E Toombs; John D Minna; Rolf A Brekken; Damith Gomika Udugamasooriya
Journal:  Oncotarget       Date:  2016-05-24
View more
  3 in total

1.  A mini-library system to investigate non-essential residues of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.

Authors:  Satya Prakash Shukla; D Gomika Udugamasooriya
Journal:  Medchemcomm       Date:  2017-10-24       Impact factor: 3.597

2.  A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells.

Authors:  Satya Prakash Shukla; Aaron Raymond; Vineeta Rustagi; Samanth R Kedika; Olivia Tran; Liye Wang; Bin Guo; D Gomika Udugamasooriya
Journal:  Bioorg Chem       Date:  2021-09-08       Impact factor: 5.275

3.  Unbiased peptoid cell screen identifies a peptoid targeting newly appeared cell surface vimentin on tumor transformed early lung cancer cells.

Authors:  Satya Prakash Shukla; Haowen Zhang; Bingliang Fang; John D Minna; D Gomika Udugamasooriya
Journal:  Bioorg Med Chem       Date:  2022-02-15       Impact factor: 3.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.